LobbyingCeliac Disease Foundation lobbying by quarter
Celiac Disease Foundation's latest lobbying report covers Q1 2026, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations.
Celiac Disease Foundation
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $20K | 1 |
| Q1 2023 | $20K | 1 |
| Q2 2023 | $20K | 1 |
| Q3 2023 | $20K | 1 |
| Q4 2023 | $20K | 1 |
| Q1 2024 | $20K | 1 |
| Q2 2024 | $20K | 1 |
| Q3 2024 | $20K | 1 |
| Q4 2024 | $20K | 1 |
| Q1 2025 | $20K | 1 |
| Q2 2025 | $20K | 1 |
| Q3 2025 | $10K | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$230K · 12 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES12 reports
- SENATE12 reports
- Food & Drug Administration (FDA)11 reports
- Health & Human Services, Dept of (HHS)11 reports
- Natl Institutes of Health (NIH)11 reports
Firms it paid
| Firm | ||
|---|---|---|
| Baker Donelson Bearman Caldwell & Berkowitz | $220K | 11 quarters |
| DB3 | $10K | 3 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 04/20for Q1 | DB3 | Under $5,000 |
| 01/20for Q4 2025 | DB3 | Under $5,000 |
| 25/10/20for Q3 2025 | DB3 | $10K |
| 25/07/21for Q3 2025 | DB3 | Under $5,000 |
| 25/07/18for Q2 2025 | Baker Donelson Bearman Caldwell & Berkowitz | $20K |
| 25/04/11for Q1 2025 | Baker Donelson Bearman Caldwell & Berkowitz | $20K |
| 25/01/10for Q4 2024 | Baker Donelson Bearman Caldwell & Berkowitz | $20K |
| 24/10/15for Q3 2024 | Baker Donelson Bearman Caldwell & Berkowitz | $20K |
| 24/07/16for Q2 2024 | Baker Donelson Bearman Caldwell & Berkowitz | $20K |
| 24/04/17for Q1 2024 | Baker Donelson Bearman Caldwell & Berkowitz | $20K |
| 24/01/16for Q4 2023 | Baker Donelson Bearman Caldwell & Berkowitz | $20K |
| 23/10/06for Q3 2023 | Baker Donelson Bearman Caldwell & Berkowitz | $20K |
| 23/07/17for Q2 2023 | Baker Donelson Bearman Caldwell & Berkowitz | $20K |
| 23/04/17for Q1 2023 | Baker Donelson Bearman Caldwell & Berkowitz | $20K |
| 23/01/10for Q4 2022 | Baker Donelson Bearman Caldwell & Berkowitz | $20K |